medication compliance
Instructed in new medication Amitriptyline to manage depression. In additon, warned of possible S/E such as coma, seizures, hallucinations, delusions, disorientation, ataxia, tremor, peripheral neuropathy, anxiety, insomnia, restlessness, drowsiness, dizziness, weakness, fatigue, headache, extrapyramidal reactions, MI, stroke, arrhythmias, heart block, orthostatic hypotension, tachycardia, ECG changes, hypertension, edema, blurred vision, tinnitus, mydriasis, increased intraocular pressure, dry mouth, nausea, vomiting, anorexia, epigastric distress, diarrhea, constipation, paralytic ileum, urine retention, agranulocytosis, thrombocytopenia, leukopenia, eosinophilia, hypoglycemia, hyperglycemia, rash, urticaria, photosensitivity, diaphoresis and hypersensitivity reaction. Instructed to take full dose at bedtime but warned patient of possible morning orthostatic hypotension. Avoid alcohol during drug therapy. Consult MD before taking other medications. Avoid activities that require alertness and good psychomotor coordination until CNS effects of drug are known. Drowsiness and dizziness usually subside after a few weeks. Dry mouth may be relieved with sugarless hard candy or gum. Saliva substitutes may be needed. Instructed to use a sun block, wear protective clothing and avoid prolonged exposure to strong sunlight. To prevent photosensitivity reactions. Do not stop drug therapy abruptly.
Instructed in new medication Aspirin to manage rheumatoid arthritis. In addition, warned of possible S/E such as tinnitus, hearing loss, nausea, GI distress, occult bleeding, dyspepsia, GI bleeding, leukopenia, hepatitis, rash, urticaria and others.
Instructed in measures to control or to live with Parkinson's disease such as exercising daily with regular rest periods, learning walking techniques, following safety precautions, obtaining adequate nutrition, obtaining emotional support, taking medication as ordered, getting help as needed, wearing an identification bracelet, etc.
Instructed in new medication Atenolol to manage hypertension. In addition, warned of possible S/E such as fatigue, lethargy, vertigo, drowsiness, dizziness, fever, bradycardia, hypotension, heart failure, intermittent claudication, nausea, diarrhea, thrombocytopenia, hyperkalemia, hypoglycemia, increased risk of developing type-two diabetes, dyspnea, bronchospasm, rash and leg pain. Instructed to take drug exactly as prescribed at the same time every day. Do not stop drug suddenly but do call prescriber if unpleasant adverse reactions occur. If pulse rate is below 60 beats/minute, stop taking drug and call prescriber. Women: notify prescriber if pregnancy occurs. Drug usage might be discontinued.
Instructed in new medication Atorvastatin to reduce cholesterol levels. In addition, warned of possible S/E such as headache, asthenia, insomnia, peripheral edema, rhinitis, pharyngitis, sinusitis, abdominal pain, dyspepsia, flatulence, nausea, constipation, diarrhea, urinary tract infection, arthritis, arthralgia, myalgia, bronchitis, rash, infection, flu-like syndrome, and allergic reaction.
Instructed in new medication Synthroid and in S/E such as nervousness, insomnia, tremor, headache, fever, tachycardia, palpitations, arrhythmias, angina pectoris, cardiac arrest, diarrhea, vomiting, menstrual irregularities, weight loss, allergic skin reactions, diaphoresis or heat intolerance.
Instructed in new medication Metaproterenol sulfate, to manage bronchial asthma. In addition, warned of possible S/E such as vertigo, headache, nervousness, dry and irritated throat, vomiting, nausea, dry mouth, etc.
Instructed in D/C planning. Instructed to keep MD appointments, take medication exactly as MD ordered and report any S/E and/or S/S to avoid further complications.
Instructed in new medication Levaquin to manage infection. In addition, warned of possible S/E such as headache, insomnia, dizziness, encephalopathy, chest pain, palpitations, vasodilation, nausea, diarrhea, vomiting, abdominal pain, dyspepsia, flatulence, vaginitis, eosinophilia, hypoglycemia, back pain, tendon rupture, rash, pruritus, hypersensitivity reactions, etc. Instructed to take drug as prescribed, even if signs and symptoms disappear. Take drug with plenty of fluids and avoid antacids, sucralfate, and products containing iron or zinc for at least 2 hours before and after each dose. Avoid excessive sunlight, use sun block, and wear protective clothing when outdoors. Stop drug usage and notify prescriber if rash or other S/S of hypersensitivity develop. Notify prescriber if patient experiences pain or inflammation. Tendon rupture can occur with drug. Instructed to Diabetic patient to monitor glucose level and notify prescriber if a hypoglycemia reaction occurs. Notify prescriber if loose stools or diarrhea occurs.
Instructed in new medication Bactroban to manage wound care. In addition, warned of possible S/E such as headache, rhinitis, pharyngitis, burning or stinging with intranasal use, taste perversion, upper respiratory tract congestion, cough with intranasal use, burning pruritis, stinging, rash, pain, and erythema with topical use. Instructed to notify prescriber immediately if no improvement occurs in 3 to 5 days or if condition worsens. Advised not to use other nasal products with Bactroban. Warned patient about local adverse reactions related to drug use. Advised not to use cosmetics or other skin products on treated area.